Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 3Gastrointestinal 2Dermatologic 2Thoracic 1Other hematologic neoplasm 1Gynecologic 1Genitourinary 1

Conditions

Colorectal Neoplasms 618Pancreatic Neoplasms 377Carcinoma, Hepatocellular 293Stomach Neoplasms 239Rectal Neoplasms 178Colonic Neoplasms 162Carcinoma, Non-Small-Cell Lung 162Esophageal Neoplasms 160Breast Neoplasms 140Neoplasms 130Neoplasm Metastasis 123Ovarian Neoplasms 117Lung Neoplasms 107Cholangiocarcinoma 106Liver Neoplasms 98Gastrointestinal Neoplasms 95Melanoma 84Biliary Tract Neoplasms 75Prostatic Neoplasms 73Endometrial Neoplasms 69Esophageal Squamous Cell Carcinoma 66Carcinoma, Renal Cell 56Sarcoma 54Squamous Cell Carcinoma of Head and Neck 53Uterine Cervical Neoplasms 48Head and Neck Neoplasms 46Adenocarcinoma Of Esophagus 45Urinary Bladder Neoplasms 39Triple Negative Breast Neoplasms 37Gastrointestinal Stromal Tumors 34

Interventions

pembrolizumab 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Colitis, Ulcerative × Gastrointestinal × 90 days × Clear all
NCT07223424 2026-04-16

PSI-Immune

University of Pittsburgh

Phase 2 Recruiting
880 enrolled
DermatologicGastrointestinalGenitourinaryGynecologicThoracic

Adenocarcinoma Of Esophagus, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Colitis, Ulcerative, Colonic Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Melanoma

NCT07089771 2026-03-20

Virtual Versus Dye-based Chromoendoscopy in Inflammatory Bowel Disease Surveillance Colonoscopy

Region Stockholm

Phase NA Not yet recruiting
480 enrolled
Gastrointestinal

Colitis, Ulcerative, Crohn Disease, Colorectal Neoplasms, Inflammatory Bowel Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡